Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes

Stopped early · Not applicable

Conditions studied: Weight Loss, PreDiabetes

In brief

The primary objective of this study is to determine whether intermittent use of continuous glucose monitor will facilitate weight loss in individuals who are overweight/obese with prediabetes.

Key facts

Study ID

NCT03844646

Run by

Stanford University

People needed

12

Starts

2019-08-01

Expected to finish

2021-12-31

Last updated by the study team

2023-01-31

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Overweight/obese (BMI 25-40 kg/m2)
• Prediabetes (fasting glucose 100-125 mg/dL and/or HbA1c 5.7-6.4%)

You may not qualify if…

• On glucose-lowering medications (e.g., metformin)
• On weight-loss medications

Where it is running

• Stanford — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.